A gene expression program executed by neutrophils and a corresponding biomarker support tumor progression across human and murine tumors.

Preclinical study findings point to new possibilities for strategies for treating metastatic TNBC patients for whom there are no specific therapies.

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

Researchers say the deep learning model may help to create leads for new cancer diagnostics, patient stratification, and future therapies.

Mass spectrometry (MS) has long been a cornerstone of chemical and biological analysis, but in biotech and biomanufacturing, it is now experiencing a renaissance. As drug modalities diversify—peptides ...

CEPI will work with Samsung Biologics to establish a scalable, rapid manufacturing process for recombinant-protein vaccines.

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

A new predictive framework reprograms T cells to sustain immune memory while preserving their ability to fight cancer and infections.

The conversion of large-scale, complex mass spectrometry data into meaningful structural insights through ChemEcho, a machine learning embedding method, published in August by investigators at ...

Shweta Maniar, global director, life sciences strategy & solutions for Google Cloud, recently discussed with GEN Edge the survey and the broader challenges faced by life sciences and healthcare users ...

The data showed that a subset of killer T cells that also interact with EBV are more prevalent in people with the chronic autoimmune disease.

Immunotherapy that blocks microglial Fcγ receptors prevents dopaminergic neuron loss in Parkinson’s disease, revealing a potential new strategy.